News

Investing.com -- Dyne Therapeutics, Inc. (NASDAQ: DYN) reported a second quarter loss that slightly missed analyst expectations as the clinical-stage biotech company continues to advance its ...
The UK’s new industrial strategy signals a decisive shift toward state-backed innovation, investment, and regulatory reform.
On July 24, 2025, the Federal Trade Commission (“FTC”) and the U.S. Department of Justice (“DOJ”) convened the second of ...
Shares in nuclear medicine play Clarity Pharmaceuticals have surged up to 12% after the company's swift and supersized $203 ...
Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...
Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...
In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
On April 10, 2025, the U.S. Food and Drug Administration (FDA) announced a landmark initiative to phase out animal testing in ...
In today's Tech Bytes, ABC's Rhiannon Alley shares, Apple is offering a subscription service to protect your devices. It's ...
Three companies led by Indian origin entrepreneurs — Qure.ai led by Prashant Warier, CRISPR Therapeutics led by Sam Kulkarni and Vertex Pharmaceuticals led by Reshma Kewalramani — figure among TIME100 ...